Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma.
BACH2, a B-cell specific transcription factor, plays a critical role in oxidative stress-mediated apoptosis. Bortezomib (Velcade(TM)) is widely used to treat relapsed mantle cell lymphoma (MCL) patients despite varying clinical outcomes. As one of the potential mechanisms of action, bortezomib was r...
Main Authors: | Zheng Chen, Eric F Pittman, Jorge Romaguera, Luis Fayad, Michael Wang, Sattva S Neelapu, Peter McLaughlin, Larry Kwak, Nami McCarty |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3732253?pdf=render |
Similar Items
-
Bach1 Induces Endothelial Cell Apoptosis and Cell-Cycle Arrest through ROS Generation
by: Xinhong Wang, et al.
Published: (2016-01-01) -
3-Methyladenine but not antioxidants to overcome BACH2-mediated bortezomib resistance in mantle cell lymphoma
by: Min Feng, et al.
Published: (2021-05-01) -
Editorial: CAR T-Cell Therapies in Hematologic Tumors
by: Marta Coscia, et al.
Published: (2020-10-01) -
Smoldering mantle cell lymphoma
by: Haige Ye, et al.
Published: (2017-12-01) -
Current trials for frontline therapy of mantle cell lymphoma
by: Raphael E. Steiner, et al.
Published: (2018-01-01)